Funded Tech Companies
Zag Bio
Zag Bio, based in Cambridge, has financial backing from AbbVie Biotech Ventures, Regeneron Pharmaceuticals and Lightspeed Venture Partners.
Company Overview
Company Name
Zag Bio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Zag Bio� has discovered a novel approach to create thymus-targeted medicines to treat and prevent autoimmune diseases by restoring central immune tolerance. Zag Bio designs bifunctional antibodies that deliver self-antigens to antigen-presenting cells in the thymus to harness the body's natural process for training immune cells to recognize and tolerate self, halting or preventing autoimmune attacks on the body's own tissues.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/28/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Cole
Company Investors
- AbbVie Biotech Ventures (Christian Schubert)
- Regeneron Pharmaceuticals
- Lightspeed Venture Partners (Shelley Chu)
- Polaris Partners (Alan Crane)
- Boxer Capital
- Sanofi Ventures
- KdT Ventures
- Mission BioCapital (Johannes Fruehauf)
- Pear VC
- JDRF T1D Fund (Sylvia Tobé)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs